Tandem Diabetes Care, Inc. (LON:0M0F)

Market Cap	769.27M
Revenue (ttm)	760.79M
Net Income (ttm)	-142.31M
Shares Out	n/a
EPS (ttm)	-2.17
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	935
Average Volume	933
Open	15.93
Previous Close	16.05
Day's Range	15.86 - 16.29
52-Week Range	15.49 - 48.13
Beta	n/a
RSI	31.45
Earnings Date	Jul 30, 2025

About Tandem Diabetes Care

Tandem Diabetes Care, Inc. designs, develops, and commercializes technology solutions for people living with diabetes in the United States and internationally. The company’s flagship product is the t:slim X2 insulin delivery system; and Tandem Mobi insulin pump, an automated insulin delivery system. It also sells single-use products, including cartridges for storing and delivering insulin, and infusion sets that connect the insulin pump to the user’s body. In addition, the company offers Tandem Device Updater used to update the pump software fr...

• Industry: Electromedical and Electrotherapeutic Apparatus
• Founded: 2006
• Employees: 2,650
• Stock Exchange: London Stock Exchange
• Ticker Symbol: 0M0F

Financial Performance

In 2024, Tandem Diabetes Care's revenue was $940.20 million, an increase of 25.74% compared to the previous year's $747.72 million. Losses were -$96.03 million, -56.86% less than in 2023.

Financial numbers in USD